Randhawa, J., Ostojic, A., Vrhovac, R., Atallah, E., & Verstovsek, S. (2012). Splenomegaly in myelofibrosis—new options for therapy and the therapeutic potential of Janus kinase 2 inhibitors. BioMed Central.
Styl cytowania ChicagoRandhawa, Jasleen, Alen Ostojic, Radovan Vrhovac, Ehab Atallah, i Srdan Verstovsek. Splenomegaly in Myelofibrosis—new Options for Therapy and the Therapeutic Potential of Janus Kinase 2 Inhibitors. BioMed Central, 2012.
Styl cytowania MLARandhawa, Jasleen, et al. Splenomegaly in Myelofibrosis—new Options for Therapy and the Therapeutic Potential of Janus Kinase 2 Inhibitors. BioMed Central, 2012.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..